NCT05595889 2022-11-29Surufatinib Combined With Irinotecan as a Second-line Treatment for Small Cell Lung CancerFujian Cancer HospitalPhase 2 Unknown40 enrolled
NCT04764006 2021-11-04Surufatinib Combined With Sintilimab for Advanced MSS-Type Colorectal Cancer : a Phase II StudyFujian Cancer HospitalPhase 2 Unknown10 enrolled